Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01147653 · ClinicalTrials.gov registry record · Phase 2
A Randomized Study of Autologous Umbilical Cord Blood Reinfusion in Children With Cerebral Palsy
A Phase 2 study, sponsored by Joanne Kurtzberg, MD.
- Completed
- Registry status
- Phase 2
- Development phase
- 63
- Enrollment target
NCT01147653 is a Phase 2 study that has completed, run by Joanne Kurtzberg, MD. The registered enrollment target is 63 participants.
The verdict
NCT01147653, a Phase 2 study, has completed, sponsored by Joanne Kurtzberg, MD.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 63 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the efficacy of a single intravenous infusion of autologous umbilical cord blood (UCB) for the treatment of pediatric patients with spastic cerebral palsy.
Interventions
- OTHER Placebo
- BIOLOGICAL Autologous UCB Reinfusion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 63 participants |
| Start Date | 2010-06 |
| Est. Completion | 2016-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01147653
The ClinicalTrials.gov registry entry for NCT01147653 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 63 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Joanne Kurtzberg, MD, which has 15 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01147653 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01147653 about?
NCT01147653 is a clinical study titled "A Randomized Study of Autologous Umbilical Cord Blood Reinfusion in Children With Cerebral Palsy". The purpose of this study is to determine the efficacy of a single intravenous infusion of autologous umbilical cord blood (UCB) for the treatment of pediatric patients with spastic cerebral palsy.
What is the current status of trial NCT01147653?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 63 participants. The study started on 2010-06. Estimated completion is 2016-03.
What interventions are being tested in trial NCT01147653?
The interventions under investigation include: Placebo (OTHER), Autologous UCB Reinfusion (BIOLOGICAL).
Who is sponsoring clinical trial NCT01147653?
This trial is sponsored by Joanne Kurtzberg, MD, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.